QueueDr is a healthcare technology company that builds AI-driven appointment management and patient access software to automatically fill cancellations, rebook no-shows, and optimize provider schedules for health systems and clinics.[1][4]
High-Level Overview
- Mission: QueueDr’s product mission is to reduce lost revenue and improve access by automating patient scheduling and filling open appointment slots using intelligent matching and integrations with EHRs and practice platforms.[1][3]
- Investment philosophy / Key sectors / Impact on the startup ecosystem: QueueDr is a portfolio company (acquired by Phreesia), not an investment firm; it operates in the healthcare IT / patient access sector and has influenced the market by demonstrating that AI-driven schedule optimization can materially improve clinic throughput and revenue capture for provider organizations.[1][4]
- What product it builds: QueueDr builds an AI scheduling platform (marketed as an appointment-access solution) that automatically matches patients to available appointment slots and fills gaps in provider schedules.[4][1]
- Who it serves: The product serves hospitals, health systems, medical groups and ambulatory clinics that use EHRs and practice management systems.[1][3]
- What problem it solves: It addresses lost revenue and inefficiency from cancellations, no-shows, and suboptimal schedule utilization by automating rescheduling and patient matching.[1][4]
- Growth momentum: Founded in 2013, QueueDr grew through partnerships and platform integrations (processing millions of API transactions monthly via some partners) and was later integrated into Phreesia’s offerings, signaling enterprise adoption and exit/acquisition traction.[1][2][4]
Origin Story
- Founding year and founder background: QueueDr was founded in 2013 by Patrick Randolph to tackle revenue loss tied to appointment no-shows and cancellations in outpatient care.[2][1]
- How the idea emerged and early traction: The startup developed a web-based platform to automatically fill cancellations and rebook no-shows; early traction included integrations with major practice platforms and processing large volumes of transactions through partner APIs, earning recognition from partners such as Greenway Health.[1][2]
- Evolution: Over time QueueDr enhanced its matching with AI and broadened enterprise integrations, leading to acquisition/integration into Phreesia’s patient access and intake ecosystem.[1][4]
Core Differentiators
- AI matching and speed: QueueDr emphasizes AI-driven patient-to-slot matching, with reported average slot-fill times measured in minutes (e.g., filling gaps in ~3.4 minutes on average in product materials).[4]
- Deep EHR/practice integrations: The company built integrations with EHRs and practice management systems, enabling automated API-driven transaction volume at enterprise scale.[1]
- Focus on revenue recovery: Product design is tightly focused on recovering lost revenue from cancellations and no-shows rather than general patient engagement features, which differentiates it from broader patient-communication vendors.[1][3]
- Proven enterprise adoption and partner recognition: QueueDr’s platform was recognized by partners (e.g., Greenway Health) and used by large practices and systems, demonstrating operational credibility.[1]
Role in the Broader Tech Landscape
- Trend alignment: QueueDr rides the trend of applying AI/automation to operational healthcare problems—specifically patient access and revenue cycle optimization—where incremental efficiency gains translate directly to financial impact for providers.[4][1]
- Why timing matters: Increasing pressure on health systems to improve revenue cycle performance, reduce waste, and improve patient access has made automated scheduling tools timely and commercially attractive.[1]
- Market forces in their favor: Widespread EHR adoption and the availability of APIs for integrations enable companies like QueueDr to plug into workflows at scale; rising interest in digital front-door and patient access technologies further supports demand.[1][3]
- Influence on ecosystem: By proving a focused, measurable ROI for schedule-fill automation, QueueDr helped validate a category of purpose-built access tools that larger platforms (such as Phreesia) seek to incorporate into end-to-end intake and revenue platforms.[1][4]
Quick Take & Future Outlook
- What’s next / trends that will shape them: For QueueDr specifically, integration into larger platforms (Phreesia) positions its scheduling tech to scale within broader intake, registration, and revenue-cycle suites as health systems favor consolidated vendors that provide measurable operational ROI.[1][4]
- How their influence may evolve: The core capability—fast, AI-driven slot filling tied into EHRs—is likely to become a standard module in patient access platforms; QueueDr’s early enterprise integrations and measured outcomes increase the chances its approach will be embedded across vendor ecosystems.[1][3][4]
Quick take: QueueDr pioneered focused, AI-powered schedule optimization that converts cancellations and no-shows into measurable revenue and access improvements; its acquisition/integration into larger patient intake platforms shows how narrow, high-impact operational innovations get absorbed into enterprise healthcare stacks to scale their impact.[1][4]
